Newlink Genetics reported 92.64M in Current Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Capricor Therapeutics CAPR:US $ 59.63M 23.2M
Celldex Therapeutics CLDX:US $ 390.7M 20.14M
Intrexon XON:US $ 153.09M 3.59M
Nektar Therapeutics NKTR:US $ 795.58M 190.55M
Newlink Genetics NLNK:US 92.64M 7.03M
Prothena PRTA:US 555.62M 29.19M